These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2624870)

  • 1. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract.
    Palle C; Ottesen B; Jørgensen J; Fahrenkrug J
    Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide histidine valine (PHV) is present and biologically active in the human female genital tract.
    Palle C; Ottesen B; Fahrenkrug J
    Regul Pept; 1992 Mar; 38(2):101-9. PubMed ID: 1574604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regional distribution of NPY-, PHM-, and VIP-containing nerves in the human female genital tract.
    Blank MA; Gu J; Allen JM; Huang WM; Yiangou Y; Ch'ng J; Lewis G; Elder MG; Polak JM; Bloom SR
    Int J Fertil; 1986; 31(3):218-22. PubMed ID: 2875963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
    Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
    Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD
    Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
    Fahrenkrug J; Emson PC
    J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
    Fahrenkrug J; Pedersen JH
    Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide and peptide histidine methionine. Presence in human follicular fluid and effects on DNA synthesis and steroid secretion in cultured human granulosa/lutein cells.
    Gräs S; Ovesen P; Andersen AN; Sørensen S; Fahrenkrug J; Ottesen B
    Hum Reprod; 1994 Jun; 9(6):1053-7. PubMed ID: 7962375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways.
    Palmer JB; Cuss FM; Barnes PJ
    J Appl Physiol (1985); 1986 Oct; 61(4):1322-8. PubMed ID: 3781947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects.
    Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B
    Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides PHI and VIP: comparison between vascular and nonvascular smooth muscle effect in rabbit uterus.
    Bardrum B; Ottesen B; Fahrenkrug J
    Am J Physiol; 1986 Jul; 251(1 Pt 1):E48-51. PubMed ID: 3755293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the neuropeptides vasoactive intestinal peptide, peptide histidine methionine and substance P on human major salivary gland secretion.
    Del Fiacco M; Quartu M; Ekström J; Melis T; Boi M; Isola M; Loy F; Serra MP
    Oral Dis; 2015 Mar; 21(2):216-23. PubMed ID: 24725136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
    Fahrenkrug J; Pedersen JH; Yamashita Y; Ottesen B; Hökfelt T; Lundberg JM
    Regul Pept; 1987 Jul; 18(1):51-61. PubMed ID: 3306816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
    Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
    Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of VIP and PHM in human intracervical arteries.
    Hansen V; Ottesen B; Allen J; Maigaard S; Forman A
    Acta Obstet Gynecol Scand; 1988; 67(8):699-701. PubMed ID: 3250182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide.
    Watanobe H; Takebe K
    Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits.
    Obal F; Opp M; Cady AB; Johannsen L; Krueger JM
    Brain Res; 1989 Jun; 490(2):292-300. PubMed ID: 2765864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
    Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
    Watanobe H; Tamura T; Takahashi K
    Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.